A wide variety of healthcare-related research is performed at the LCN, from biosensing to imaging, diagnostics and therapeutics.

High-speed, ultra low volume protein denaturation: Microfluidics and fluorescence spectroscopy is combined in a novel nanolitre assay for drug discovery, diagnostics and pathogen detection.

Label-free technology for drug-target interactions: Arrays of diving-board-shaped cantilevers are used to detect small molecule drugs, proteins, virus particles and bacterial cells. Read our press release on role of cantilevers in tackling hospital superbugs.

Cancer cell detection from LCN spin-out Endomagnetics:  The SentiMag, a magnetic detecting device for use in breast cancer, has been developed to allow specialists to monitor the spread of cancer cells more easily.

Recent news on the Endomagnetics spin-out can be read here.